- AU$3.24m
- AU$2.65m
- AU$0.62m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.12 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -410.65% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.93 | 0.63 | 0.77 | 0.9 | 0.62 | n/a | n/a | 9.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Directors
- Julian Chick CHM
- Michelle Gallaher CEO
- Misha McPherson COO
- Damon Rasheed EDR
- Erik Norum OTH
- Scott Sorochak OTH
- Jason Weaver OTH
- David Lilja SEC
- Mark Ziirsen DRC (58)
- Megan Robertson NED
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 17th, 1994
- Public Since
- March 7th, 1996
- No. of Employees
- 3
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 124,527,257.09
- Address
- Engine House, 105 Wellington Street, ST KILDA, 3182
- Web
- https://www.shareroot.co/
- Phone
- +61 894209300
- Auditors
- William Buck Audit (Vic) Pty Ltd
Upcoming Events for OPL
Opyl Ltd Annual Shareholders Meeting
Similar to OPL
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Opyl share price?
As of Today at 22:29 UTC, shares in Opyl are trading at AU$0.03. This share price information is delayed by 15 minutes.
How has the Opyl share price performed this year?
Shares in Opyl last closed at AU$0.03 and the price had moved by +30.32% over the past 365 days. In terms of relative price strength the Opyl share price has outperformed the ASX All Ordinaries Index by +18.7% over the past year.
What are the analyst and broker recommendations for Opyl?
There is no consensus recommendation for this security.
What is the Opyl dividend yield?
Opyl does not currently pay a dividend.
Does Opyl pay a dividend?
Opyl does not currently pay a dividend.
When does Opyl next pay dividends?
Opyl does not currently pay a dividend.
How do I buy Opyl shares?
To buy shares in Opyl you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Opyl?
As of the previous close price of AU$0.03, shares in Opyl had a market capitalisation of AU$3.11m.
Where are Opyl shares listed?
Here are the trading details for Opyl:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: OPL
What kind of share is Opyl?
Based on an overall assessment of its quality, value and momentum Opyl is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Opyl share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Opyl share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Opyl. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -15.72%.
As of the last closing price of AU$0.03, shares in Opyl were trading -18.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Opyl PE Ratio?
The Opyl PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Opyl?
Opyl's management team is headed by:
- Julian Chick - CHM
- Michelle Gallaher - CEO
- Misha McPherson - COO
- Damon Rasheed - EDR
- Erik Norum - OTH
- Scott Sorochak - OTH
- Jason Weaver - OTH
- David Lilja - SEC
- Mark Ziirsen - DRC
- Megan Robertson - NED